Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-73.63	21.60	81.92
Graham Fair Price	41.50	0.15	0.10
PEG	-64.98	0.17	-0.48
Price/Book	5.06	0.53	0.51
Price/Cash Flow	-19.11	-70.25	-58.97
Prices/Earnings	-47.47	16.74	31.86
Price/Sales	-47.47	0.30	0.57
Price/FCF	-19.11	-70.25	-58.97
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.04	0.04
Operating Margin	0.00	< 0.005	< 0.005
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	96.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	1.71	-0.60	183.03
Dividends QOQ	0.00	< 0.005	100.00
EBIT QOQ	1.15	1.00	-13.26
EPS QOQ	-0.67	1.00	50.00
FCF QOQ	-1.14	0.12	-89.67
Revenue QOQ	-0.41	1.00	145.04
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-6.05	-3.02	50.00
Days Sales Outstanding (DSO)	107.39	53.70	-50.00
Inventory Turnover	-14.88	-29.75	-100.00
Debt/Capitalization	< 0.005	0.03	166.19
Quick Ratio	1.80	1.80	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.35	0.35	0.05
Cash	0.07	0.07	0.05
Capex	< 0.005	< 0.005	-100.11
Free Cash Flow	< 0.005	< 0.005	11.75
Revenue	0.31	0.62	100.11
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.23	2.23	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-31.14	-6.49	79.15
Naive Interpretation	Member

06 - Financial Health · Bad

Rating